Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms: The European Flow-Redirection Intraluminal Device Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Safety and Efficacy of Aneurysm Treatment with the WEB: Results of the WEBCAST 2 Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Enhancing brain lesions after endovascular treatment of aneurysms

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Endovascular treatment for cerebral venous sinus thrombosis - a single center study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Vector Concentration used for Stenosis Assessment in the Carotid Artery before and after Carotid Stenting

    Publikation: Bidrag til tidsskriftKonferenceartikelForskningpeer review

  3. Comparison of PED and FRED Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity Score-Matched Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • M Killer-Oberpfalzer
  • N Kocer
  • C J Griessenauer
  • H Janssen
  • T Engelhorn
  • M Holtmannspötter
  • J H Buhk
  • T Finkenzeller
  • G Fesl
  • J Trenkler
  • W Reith
  • A Berlis
  • K Hausegger
  • M Augustin
  • C Islak
  • B Minnich
  • M Möhlenbruch
Vis graf over relationer

BACKGROUND AND PURPOSE: Endoluminal reconstruction with flow-diverting stents represents a widely accepted technique for the treatment of complex intracranial aneurysms. This European registry study analyzed the initial experience of 15 neurovascular centers with the Flow-Redirection Intraluminal Device (FRED) system.

MATERIALS AND METHODS: Consecutive patients with intracranial aneurysms treated with the FRED between February 2012 and March 2015 were retrospectively reviewed. Complications and adverse events, transient and permanent morbidity, mortality, and occlusion rates were evaluated.

RESULTS: During the defined study period, 579 aneurysms in 531 patients (median age, 54 years; range, 13-86 years) were treated with the FRED. Seven percent of patients were treated in the acute phase (≤3 days) of aneurysm rupture. The median aneurysm size was 7.6 mm (range, 1-36.6 mm), and the median neck size 4.5 mm (range, 1-30 mm). Angiographic follow-up of >3 months was available for 516 (89.1%) aneurysms. There was progressive occlusion witnessed with time, with complete occlusion in 18 (20%) aneurysms followed for up to 90 ± 14 days, 141 (82.5%) for 180 ± 20 days, 116 (91.3%) for 1 year ± 24 days, and 122 (95.3%) aneurysms followed for >1 year. Transient and permanent morbidity occurred in 3.2% and 0.8% of procedures, respectively. The overall mortality rate was 1.5%.

CONCLUSIONS: This retrospective study in real-world patients demonstrated the safety and efficacy of the FRED for the treatment of intracranial aneurysms. In most cases, treatment with a single FRED resulted in complete angiographic occlusion at 1 year.

TidsskriftAJNR. American journal of neuroradiology
Udgave nummer5
Sider (fra-til)841-847
Antal sider7
StatusUdgivet - maj 2018

ID: 56302113